Sunway Healthcare Holdings Berhad (KLSE:SUNMED)
Malaysia
· Delayed Price · Currency is MYR 1.870
+0.010 (0.54%)
At close: Apr 28, 2026
KLSE:SUNMED Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 2,200 | 1,852 | 1,457 | 1,065 |
| Revenue Growth (YoY) | 18.78% | 27.15% | 36.83% | - |
| Cost of Revenue | 817.01 | 667.57 | 556.85 | 403.45 |
| Gross Profit | 1,383 | 1,185 | 900.04 | 661.33 |
| Selling, General & Admin | 882.45 | 699.7 | 529.6 | 388.79 |
| Other Operating Expenses | 195.75 | 149.78 | 110.04 | 78.09 |
| Operating Expenses | 1,086 | 857.56 | 643.05 | 466.76 |
| Operating Income | 297.58 | 327.34 | 256.99 | 194.57 |
| Interest Expense | -59.21 | -46.2 | -19.9 | -15.14 |
| Interest & Investment Income | 25.13 | 17.34 | 7.04 | 7.42 |
| Currency Exchange Gain (Loss) | 7.42 | 1.86 | 0 | - |
| Other Non Operating Income (Expenses) | -1.79 | -1.48 | -1.52 | 0.02 |
| EBT Excluding Unusual Items | 269.13 | 298.85 | 242.62 | 186.87 |
| Gain (Loss) on Sale of Assets | 0.12 | - | - | - |
| Other Unusual Items | 4.99 | - | 0.17 | 57.53 |
| Pretax Income | 274.24 | 298.85 | 242.78 | 244.4 |
| Income Tax Expense | 22.02 | 41.34 | 61.15 | 34.49 |
| Earnings From Continuing Operations | 252.22 | 257.51 | 181.63 | 209.91 |
| Minority Interest in Earnings | -0.01 | -0.01 | -0.01 | -0.01 |
| Net Income | 252.21 | 257.5 | 181.63 | 209.9 |
| Net Income to Common | 252.21 | 257.5 | 181.63 | 209.9 |
| Net Income Growth | -2.05% | 41.78% | -13.47% | - |
| Shares Outstanding (Basic) | 11,500 | 11,500 | 9,570 | 8,932 |
| Shares Outstanding (Diluted) | 11,500 | 11,500 | 10,925 | 10,925 |
| Shares Change (YoY) | - | 5.26% | - | - |
| EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 |
| EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 |
| EPS Growth | -2.19% | 34.89% | -13.55% | - |
| Free Cash Flow | -110.35 | -110.66 | -589.79 | -421.58 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.05 | -0.04 |
| Gross Margin | 62.87% | 63.96% | 61.78% | 62.11% |
| Operating Margin | 13.52% | 17.67% | 17.64% | 18.27% |
| Profit Margin | 11.46% | 13.90% | 12.47% | 19.71% |
| Free Cash Flow Margin | -5.01% | -5.97% | -40.48% | -39.59% |
| EBITDA | 477.42 | 452.48 | 354.64 | 262.25 |
| EBITDA Margin | 21.70% | 24.43% | 24.34% | 24.63% |
| D&A For EBITDA | 179.84 | 125.15 | 97.64 | 67.68 |
| EBIT | 297.58 | 327.34 | 256.99 | 194.57 |
| EBIT Margin | 13.52% | 17.67% | 17.64% | 18.27% |
| Effective Tax Rate | 8.03% | 13.83% | 25.19% | 14.11% |
Source: S&P Capital IQ. Standard template. Financial Sources.